Back

Annexon targets functional recovery in geographic atrophy and Guillain-Barré trials

Verifying
  • Annexon is focusing trials on functional outcomes in geographic atrophy and Guillain-Barré syndrome.
  • Patients’ vision and physical recovery are among the real-world benefits being assessed.
  • The source also mentions the ARCHER II trial without completing its latest update.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.